R-Spondin 2 (RSPO2), a critical and novel enhancer of preexisting WNT signals that binds to receptors of the leucine-rich repeat-containing G-protein coupled receptor (LGR) family, enhanced cancer stemness in susceptible PDAC cells. The gene discussed is RSPO2; the disease is cancer.